Cancer experts from Willis-Knighton Cancer Center have been featured in several national venues this fall. In September Lane R. Rosen, MD, director of radiation oncology, presented at the American Society for Radiation Oncology annual meeting in Boston. Rosen was featured in a “meet the experts” segment of the conference with “Pioneering Cancer Treatment,” a look into how Willis-Knighton, using IBA’s compact cyclotron technology, established a proton therapy center in just 13 months. At the same meeting Rosen was also featured at the Samsung booth, discussing how he and the team at the Cancer Center integrated the Samsung/Neurologica BodyTom imaging into the brachytherapy suite at the center, enhancing accuracy and improving patient safety and comfort. 

Willis-Knighton Cancer Center was also featured in a national publication, the September issue of Wavelength, a magazine published by Swedish technology company Elekta, which manufactured the center’s two new Versa HD linear accelerators. The article cited the accomplishments of Willis-Knighton’s one-week HDR Brachytherapy Scholarship Program supported by the American Brachytherapy Society. During this program medical students receive an intense immersion in brachytherapy clinical value and practice. Another article in the publication recognizes Willis-Knighton’s Brachytherapy Center of Excellence, launched in 1997. A third story details the analysis and preparation that went into the center’s decision to purchase two Versa HD linear accelerators to enhance patient care. Completing these features was a fourth one focusing on what Wavelength termed, “Willis-Knighton’s world-class medical physics program” under the direction of Terry Wu, PhD, chief medical physicist and director of the WK Medical Physics Residency.